Lexaria Bioscience Corp. - Warrant (NQ:LEXXW)
0.0394
+0.0183
(+86.73%)
Streaming Delayed Price
Updated: 3:13 PM EST, Nov 26, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 2,422 |
| Open | 0.0419 |
| Bid (Size) | 0.0244 (7,800) |
| Ask (Size) | 0.0414 (100) |
| Prev. Close | 0.0211 |
| Today's Range | 0.0394 - 0.0419 |
| 52wk Range | 0.0180 - 1.310 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Lexaria Bioscience Corp. Provides Strategic Update
October 09, 2025
Performance
More News
Read More
Lexaria Attending BIO International Convention
June 05, 2025
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
August 06, 2025
Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide
February 20, 2025
Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy
February 11, 2025
Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
February 06, 2025
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
April 03, 2025
Lexaria's Human GLP-1 Study #5 Begins Dosing
April 02, 2025
Frequently Asked Questions
Is Lexaria Bioscience Corp. - Warrant publicly traded?
Yes, Lexaria Bioscience Corp. - Warrant is publicly traded.
What exchange does Lexaria Bioscience Corp. - Warrant trade on?
Lexaria Bioscience Corp. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Warrant?
The ticker symbol for Lexaria Bioscience Corp. - Warrant is LEXXW on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Warrant?
The current price of Lexaria Bioscience Corp. - Warrant is 0.0394
When was Lexaria Bioscience Corp. - Warrant last traded?
The last trade of Lexaria Bioscience Corp. - Warrant was at 11/26/25 03:13 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.